A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

NCT00002195 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Amprenavir
DRUG: Lamivudine
DRUG: Zidovudine

Sponsor

Glaxo Wellcome